• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biocryst Pharma Inc (NQ: BCRX )

    8.280 +0.030 (+0.36%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,829,196
    Open 8.210
    Bid (Size) 8.100 (1)
    Ask (Size) 8.440 (1)
    Prev. Close 8.250
    Today's Range 8.010 - 8.336
    52wk Range 4.030 - 8.880
    Shares Outstanding 185,583,896
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
    EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:BCRX),(NASDAQ:VERU),(NASDAQ:CMRX),(NASDAQ:SIGA) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Exposures COVID-19
    BioCryst Pharmaceuticals (BCRX) Q2 2024 Earnings Call Transcript
    BCRX earnings call for the period ending June 30, 2024. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial

    Performance

    YTD
    +36.41%
    +36.41%
    1 Month
    +10.25%
    +10.25%
    3 Month
    +22.85%
    +22.85%
    6 Month
    +53.05%
    +53.05%
    1 Year
    +17.45%
    +17.45%

    More News

    Read More
    7 Small-Cap Stocks to Buy for Large-Scale Gains
    Via InvestorPlace
    A Preview Of BioCryst Pharma's Earnings
    Via Benzinga
    What's Going On With BioCryst Pharmaceuticals Stock?
    Via Benzinga
    Where BioCryst Pharma Stands With Analysts
    Via Benzinga
    What 7 Analyst Ratings Have To Say About BioCryst Pharma
    Via Benzinga
    Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
    From FN Media Group LLC
    Via GlobeNewswire
    3 Insider-Buy Stocks to Add to Your Watchlist Now
    Via MarketBeat
    Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday
    Via The Motley Fool
    BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
    Via Benzinga
    BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    BCRX Stock Earnings: BioCryst Pharma Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Hidden Penny Gems: 7 Stocks With Triple-Digit Growth Prospects
    Via InvestorPlace
    BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    What's Going On With BioCryst Stock After Earnings?
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Earnings Scheduled For February 26, 2024
    Via Benzinga
    Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.